Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001835544-25-000004
Filing Date
2025-12-23
Accepted
2025-12-23 16:37:05
Documents
1
Period of Report
2025-12-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4695
  Complete submission text file 0001835544-25-000004.txt   6234
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Issuer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 609 SW 8TH STREET SUITE 510 BENTONVILLE AR 72712
Business Address
Ugwumba Chidozie (Reporting) CIK: 0001835544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39834 | Film No.: 251601192